Pharmacogenomics IND SNP Clinical Trial - Alectinib and Single Nucleotide Polymorphisms | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pharmacogenomics IND SNP Clinical Trial - Alectinib and Single Nucleotide Polymorphisms	ALK-Positive Non-Small Cell Lung Cancer (NSCLC)	Active, not recruiting	Phase 2 / Phase 3	2026-10-08		NCT05987956

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Medicine Invention Design, Inc	1
Omnicure Clinical Research	1
Responsible Party: Individual Sponsor: Han Xu, M.D., Ph.D., FAPCR, Medical Director, IRB Chair	1
UnitedHealthcare	8

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Medicine Invention Design, Inc. - IORG0007849 - NPI 1023387701	Rockville	United States	2
Omnicure Clinical Research	Doral	United States	4